Therma Bright (TSE:THRM) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Therma Bright has signed a letter of intent with DME Authority to expand the U.S. distribution of its Venowave VW5 devices, targeting a $6 million inventory purchase within the first half of 2025. This partnership aims to enhance patient access to the mobile mechanical compression solution across multiple healthcare channels.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
